Call it Mighty Mouse: Breakthrough leaps Alzheimer’s research hurdle
UCI-led study reveals crucial mechanisms contributing to the disease
July 31, 2019
KEYWORD
stem cells
UCI team pioneers cancer treatment that targets bone metastases while sparing bone
New, safer approach using engineered stem cells could reduce need for chemotherapy
July 08, 2019
Nanotechnology treatment shows promise against multiple sclerosis
UCI-led stem cell study sets stage for human testing
June 05, 2019
Leslie Thompson gets $6 million CIRM grant to advance Huntington’s disease treatments
Leslie Thompson of the Sue & Bill Gross Stem Cell Research Center and UCI MIND has been awarded $6 million by the California Institute for Regenerative Medicine to continue her CIRM-supported efforts to create stem cell treatments for Huntington’s disease. The funding will allow the Thompson lab to conduct the late-stage testing needed to apply […]
January 30, 2019
UCI to mark Stem Cell Awareness Day with Oct. 30 lab tour, lecture
Talk will address intersection of politics and science, need to renew research funding
October 18, 2018
Healing from within
UCI stem cell researcher confronts science denialism, deceptive clinics and dwindling funding
May 14, 2018
Wound warriors
UCI alumni, doctor engineer potential stem cell treatment for diabetic foot ulcers
January 22, 2018
Stem cell researchers receive $1.6 million from CIRM for spinal cord injury studies
UCI stem cell researchers have received $1.6 million from the California Institute for Regenerative Medicine to create a new line of neural stem cells that can be used to treat chronicle cervical spinal cord injury. Aileen Anderson, director of the Sue & Bill Gross Stem Cell Research Center at UCI, will lead the effort. The […]
December 22, 2017
UCI stem cell therapy attacks cancer by targeting unique tissue stiffness
Study shows success in stamping out deadly metastatic cells
July 26, 2017
Stem cell therapy for retinitis pigmentosa found safe, well-tolerated in first-stage clinical trial
Sue & Bill Gross Stem Cell Research Center researchers have reported that a therapy they created to cure retinitis pigmentosa is safe and well-tolerated, with no immunological issues, by the first group of patients enrolled in an ongoing phase I/II clinical trial. Led by the regenerative medicine company jCyte, the trial has successfully undergone four […]
July 15, 2016